December 17, 2020 (LifeSiteNews) — As COVID-19 vaccine doses roll out across the world, top doctors increasingly tout a generic drug called ivermectin as a newly recognized potential “cure” for the virus.
Ivermectin, a Nobel Prize–winning anti-parasitic agent, has been the subject of dozens of studies and anecdotal success stories since it was found to reduce COVID-19 in a laboratory earlier this year. The Food and Drug Administration (FDA) has refused emergency authorization of ivermectin to treat the novel coronavirus, stating for months that “[m]ore testing is needed.”
Nevertheless, several medical experts testified to the benefits of the drug for COVID-19 patients at a hearing held by the Senate Homeland Security Committee last week. In an impassioned speech, Dr. Pierre Kory, an intensive care specialist from Wisconsin, spoke to what he called “the miraculous effectiveness of ivermectin.”
Kory is a founding member of Front Line Covid-19 Critical Care Alliance (FLCCC), “a group of highly published leaders in critical care” seeking to stop excessive mortality from COVID-19. FLCCC has developed a treatment regimen incorporating ivermectin, which the group claims has led to up to 83% lower-than-average COVID-19 death rates in hospitals that have applied it.
Ivermectin “basically obliterates transmission of this
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors